
    
      The objective of the study is to determine the effect of a single dose of bilastine 20 mg on
      nasal symptoms of allergic rhinitis provoked by spending 4 hours in the Vienna Challenge
      Chamber . This effect will be compared to that action of Cetirizine 10 mg, Fexofenadine 120
      mg, and placebo. To explore the onset of action, patients will receive study drug two hours
      after the start of the provocation on Day 1.Patients will remain in theVCC for an additional
      four hours. On Day 2, patients will return to the VCC post-dose hours 22-26.
    
  